These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23858494)

  • 21. Monitoring the impact of HPV vaccine in males-Considerations and challenges.
    Brotherton JML; Giuliano AR; Markowitz LE; Dunne EF; Ogilvie GS
    Papillomavirus Res; 2016 Dec; 2():106-111. PubMed ID: 29074169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs.
    Isidean SD; Tota JE; Gagnon JA; Franco EL
    Expert Rev Vaccines; 2015 Jan; 14(1):119-33. PubMed ID: 25266065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vaccination against HPV in adults].
    Gil Á
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():22-5. PubMed ID: 20084345
    [No Abstract]   [Full Text] [Related]  

  • 24. Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the Southeastern United States.
    Wheldon CW; Daley EM; Buhi ER; Nyitray AG; Giuliano AR
    Vaccine; 2011 Oct; 29(45):8060-5. PubMed ID: 21864615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sexual healthcare professionals' views on HPV vaccination for men in the UK.
    Nadarzynski T; Smith HE; Richardson D; Ford E; Llewellyn CD
    Br J Cancer; 2015 Dec; 113(11):1599-601. PubMed ID: 26575602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art.
    Toh ZQ; Licciardi PV; Fong J; Garland SM; Tabrizi SN; Russell FM; Mulholland EK
    Vaccine; 2015 Sep; 33(39):5042-50. PubMed ID: 26271829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(50):1705-8. PubMed ID: 22189893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Who should be targeted for vaccination against anal cancer?
    Harper DM; Vierthaler SL
    Lancet Oncol; 2011 Sep; 12(9):828-9. PubMed ID: 21865086
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study.
    Haeussler K; Marcellusi A; Mennini FS; Favato G; Picardo M; Garganese G; Bononi M; Costa S; Scambia G; Zweifel P; Capone A; Baio G
    Value Health; 2015 Dec; 18(8):956-68. PubMed ID: 26686779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV.
    de Pokomandy A; Rouleau D; Ghattas G; Trottier H; Vézina S; Coté P; Macleod J; Allaire G; Hadjeres R; Franco EL; Coutlée F
    Clin Infect Dis; 2011 May; 52(9):1174-81. PubMed ID: 21364075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of human papillomavirus vaccine in HIV-infected men for the prevention of anal dysplasia and cancer.
    Cachay ER; Mathews WC
    AIDS Rev; 2014; 16(2):90-100. PubMed ID: 24818632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V; Murtagh J
    Issues Emerg Health Technol; 2007 Dec; (109):1-8. PubMed ID: 18062141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care use and opportunities for human papillomavirus vaccination among young men who have sex with men.
    Meites E; Krishna NK; Markowitz LE; Oster AM
    Sex Transm Dis; 2013 Feb; 40(2):154-7. PubMed ID: 23321994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV 16/18 prevalence reduced 3 years following vaccine introduction.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(2):254. PubMed ID: 24963520
    [No Abstract]   [Full Text] [Related]  

  • 35. HPV vaccination.
    Stanley M; O'Mahony C; Barton S
    BMJ; 2014 Jul; 349():g4783. PubMed ID: 25073784
    [No Abstract]   [Full Text] [Related]  

  • 36. Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.
    Wang CJ; Sparano J; Palefsky JM
    Surg Oncol Clin N Am; 2017 Jan; 26(1):17-31. PubMed ID: 27889034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel method to value real options in health care: the case of a multicohort human papillomavirus vaccination strategy.
    Favato G; Baio G; Capone A; Marcellusi A; Saverio Mennini F
    Clin Ther; 2013 Jul; 35(7):904-14. PubMed ID: 23806328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papillomavirus and cancers: should we extend vaccination to boys in France?
    Abramowitz L; Descamps P; Denis F; Dommergues MA; Pradat P; St Guily JL; Judlin P
    J Public Health (Oxf); 2017 Dec; 39(4):e229-e234. PubMed ID: 27679660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
    Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
    Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of HPV 16, 18 vaccination in Brazil.
    Goldie SJ; Kim JJ; Kobus K; Goldhaber-Fiebert JD; Salomon J; O'shea MK; Xavier Bosch F; de Sanjosé S; Franco EL
    Vaccine; 2007 Aug; 25(33):6257-70. PubMed ID: 17606315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.